Protective role of beta-blockers in chemotherapy-induced cardiotoxicity—a systematic review and meta-analysis of carvedilol

Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy ± trastuzumab

(2018) Dorothy M. Gujral et al.   BREAST

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

(2018) Mônica Samuel Avila et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity

(2017) Maryam Nabati et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

(2017) Edith Pituskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial

(2017) Siri Lagethon Heck et al.   European Heart Journal-Cardiovascular Imaging

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

(2016) Geeta Gulati et al.   EUROPEAN HEART JOURNAL

Preventive role of carvedilol in adriamycin-induced cardiomyopathy

(2016) Rajesh Jhorawat et al.   INDIAN JOURNAL OF MEDICAL RESEARCH

PROTECTIVE EFFECT OF BETA-BLOCKERS ON CHEMOTHERAPY INDUCED CARDIOMYOPATHY: A META-ANALYSIS OF PROSPECTIVE STUDIES

(2016) Carlos R. Manrique et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis

(2015) Seongseok Yun et al.   POSTGRADUATE MEDICAL JOURNAL

Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study

(2014) Ines Vaz-Luis et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up

(2013) Ali Elitok et al.   Cardiology Journal

Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies

(2013) Bonnie Ky et al.   CIRCULATION RESEARCH

Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity

(2013) Kazuaki Negishi et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

(2012) Mehmet G. Kaya et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

(2012) Jersey Chen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Complications of Breast Cancer Therapy in Older Adults

(2011) C. Shenoy et al.   ONCOLOGIST

Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up

(2010) Peter Georgakopoulos et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines

(2010) D. Bovelli et al.   ANNALS OF ONCOLOGY

Competing Causes of Death for Women With Breast Cancer and Change Over Time From 1975 to 2003

(2008) Xianglin L. Du et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study

(2008) A. C. Mertens et al.   JNCI-Journal of the National Cancer Institute